You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The field of bacterial genetics has been restricted for many years to Escherichia coli and a few other genera of aerobic or facultatively anaerobic bacteria such as Pseudomonas, Bacillus, and Salmonella. The prevailing view up to recent times has been that anaerobic bacteria are interesting organisms but nothing is known about their genetics. To most microbiologists, anaerobic bacteria appeared as a sort of distant domain, reserved for occasional intrusions by taxonomists and medical microbiologists. By the mid-1970s, knowledge of the genetics and molecular biology of anaerobes began to emerge, and then developed rapidly. but also im This was the result of advances in molecular biology techn...
Imagine that you are the CEO of a software company. You know you compete in an environment that does not permit you to treat innovation as a secondary issue. But how should you manage your software innovation to get the most out of it? This book will provide you with the answer. Software innovation is multifaceted and the approaches used by companies can be very different. The team of authors that wrote this book took the assumption that there is no such thing as a universal software engineering process or innovation process. Some things work well for a certain company, others do not. The book is organized around what the authors call eight fundamental practice areas for innovation with soft...
Mark Chase There are many literature resources available to molecular biologists wishing to assess genetic variation, but the myriad of techniques and approaches potentially available to the plant breeder and the evolutionary biologist is truly bewildering, and most have never been evaluated side-by-side on the same sets of samples. Additionally, it is often not recognized that tools that are useful for breeders can often be adapted for use in evolutionary studies and vice versa, but this is generally the case. The borderline between population genetics and phylogenetics is vague and difficult to assess, and a combination of both types of tools is best when it is not clear with which area on...
Since the independent invention of DNA sequencing by Sanger and by Gilbert 30 years ago, it has grown from a small scale technique capable of reading several kilobase-pair of sequence per day into today's multibillion dollar industry. This growth has spurred the development of new sequencing technologies that do not involve either electrophoresis or Sanger sequencing chemistries. Sequencing by Synthesis (SBS) involves multiple parallel micro-sequencing addition events occurring on a surface, where data from each round is detected by imaging. New High Throughput Technologies for DNA Sequencing and Genomics is the second volume in the Perspectives in Bioanalysis series, which looks at the elec...
Dit jaar wordt Raphael de Smedt zestig jaar. Sinds 1987 leidt hij het Departement der Gedrukte Werken van de Koninklijke Bibliotheek van Belgie. Sedert meer dan dertig jaar heeft hij zich op het gebied van de geschiedenis, de kunstgeschiedenis en de literatuurgeschiedenis verdienstelijk gemaakt. Een zestigtal vrienden uit tien landen brengen de veelzijdige vorser hulde in vier delen van de reeks "Miscellanea Neerlandica", gewijd aan het verleden van de Lage Landen tot het einde van het Ancien Regime. Belangrijke aspecten van zijn onderzoek worden in een uitgebreide biografie en bibliografie belicht.
The biggest hurdle between you and your plans for growth is this: nobody knows you. This is true if you’re a freelancer, an employee, an executive, even a company founder. You may be going all out with your company brand, but you’ve neglected to hone your own. But the first thing your business needs to grow, is you. If you feel like there is way more potential than you are currently leveraging, this book is for you. It is for those wanting to scale their business. For those sitting on a great idea with nowhere to go next. For those experts looking for ways to share the knowledge. For those corporate execs who need to find the next competitive edge. And for those who simply want to find a...
People want to change things, improve the world. Our mind cannot live without meaning. Just like the body asks for food. We all know that we have the leverage to make things happen. It’s important to know what to do, but it’s even more important to remember why you do what you do. Leaving a legacy is about impact surviving the erosion of time. About scaling and accelerating positive impact. Be ready to get inspired about leaving your own legacy. How do you leave a legacy? What drives a legacy? How about your legacy statement? And how about increasing your impact? Will you choose for scaling up, scaling deep, scaling out, or maybe even scaling down? Get carried away by the impact point of...
A weekly record of scientific progress.
This volume focuses on pharmaceutical biotechnology as a key area of life sciences. The complete range of concepts, processes and technologies of biotechnology is applied in modern industrial pharmaceutical research, development and production. The results of genome sequencing and studies of biological-genetic function are combined with chemical, micro-electronic and microsystem technology to produce medical devices and diagnostic biochips. A multitude of biologically active molecules is expanded by additional novel structures created with newly arranged gene clusters and bio-catalytic chemical processes. New organisational structures in the co-operation of institutes, companies and networks enable faster knowledge and product development and immediate application of the results of research and process development. This book is the ideal source of information for scientists and engineers in research and development, for decision-makers in biotech, pharma and chemical corporations, as well as for research institutes, but also for founders of biotech companies and people working for venture capital corporations.
The past ten years are characterized by a strong growth in entrepreneurship and the accelerated creation of new businesses offering innovative products and services. The focus of this book is on startups and scaleups intending to scale their business through collaboration with corporates, primarily in the capacity of client or venture partner. No startup or scaleup can go-it-alone entirely and is required to collaborate with other partners to ensure growth. It is crucial for startups and scaleups to think beyond (corporate) venture capital financings and actively use a vast spectrum of corporate partnering arrangements to scale their business. This book thus takes an expansive approach and a...